^
    over1year
    The Rac inhibitor HV-107 as a potential therapeutic for metastatic breast cancer. (PubMed, Mol Med)
    The findings indicate that HV-107 exhibits promising potential as a therapeutic medication utilizing Rac inhibition mechanisms to address metastasis formation in TNBC.
    Journal • Metastases
    |
    CDC42 (Cell Division Cycle 42) • PAK2 (P21 (RAC1) Activated Kinase 2)
    |
    HV-107